Research Article
BibTex RIS Cite

Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi

Year 2018, Volume: 18 Issue: 2, 420 - 425, 31.08.2018

Abstract

Adaçayı; Lamiaceae ailesine ait, aromatik, akdeniz kökenli bir bitkidir. Tüm dünyada, adaçayı, çeşitli hastalıklara deva bulmak ve hastalıklardan korunmak amacıyla yüzyıllardır geleneksel tedavide kullanılmaktadır. Adaçayı; sineol,borneol,rozmarinik asit, karnasol ve karnosik asitte dahil olmak üzere bir çok aktif bileşen ve esansiyal yağ içerir. Bu içeriği sayesinde antioksidan, antibakteriyel, anti-inflamatuar, antitümör gibi bir çok yararlı özelliğe sahip olmakla birlikte Alzheimer ve diyabet gibi çeşitli hastalıklarda da etkilidir. Bunun yanı sıra, Adaçayı bitkisinin bir çok kanser hücre hattı üzerinde etkili olduğunu belirten birçok çalışma mevcuttur. Bu çalışmada ise adaçayı bitkisinin, birincil kemik tümörlerinin en malignant ve en yaygın görünen türü olan osteosarkoma hücreleri üzerindeki sitotoksik etkisinin incelenmesi amaçlanmıştır. Bu amaçla geleneksel tedaviden esinlenerek adaçayı infüzyon solüsyonu olarak hazırlanmış ve U-2 OS osteosarkoma hücre hattı 3 gün boyunca çeşitli hacim oranlarında (1/1000, 1/100, 1/75, 1/50 ve 1/25 hacim/hacim) infüzyon solüsyonuna maruz bırakılmıştır. Bu süre sonunda hücre canlılığı nötral kırmızısı canlılık testi ile ölçülmüştür. Nötral kırmızısı canlılık testine göre 1/1000, 1/100, 1/75, 1/50 and 1/25 hacim oranlarında verilen infüzyon solüsyonu U-2 OS hücrelerinin canlılığını sırasıyla %3, %4, %26, %27 ve %29 oranında azaltmıştır. Elde edilen sonuçlar, adaçayı bitkisinin osteosarkoma hücreleri üzerinde sitotoksik etkisinin olduğunu desteklemektedir.

References

  • Abu-Darwish, M.S. et al., 2013. Essential Oil of Common Sage ( Salvia officinalis L.) from Jordan: Assessment of Safety in Mammalian Cells and Its Antifungal and Anti-Inflammatory Potential. BioMed Research International, 2013, pp.1–9.
  • Ando, K. et al., 2013. Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers, 5, pp.591–616..
  • Bauer, J. et al., 2012. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1. The Journal of pharmacology and experimental therapeutics, 342(1), pp.169–76..
  • Behradmanesh, S., Derees, F. & Rafieian, M., 2013. Effect of Salvia officinalis on diabetic patients. Journal of Renal Injury Prevention, 2(2), pp.51–4.
  • Garcıa, C.S.C. et al., 2016. Pharmacological perspectives from Brazilian Salvia officinalis (Lamiaceae): antioxidant, and antitumor in mammalian cells. Anais da Academia Brasileira de Ciências, 88(1), pp.281–292.
  • Hirahata, M. et al., 2016. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Cancer Medicine, 5(5), pp.892–902.
  • Jantová , S. et al., 2014. Salvia officinalis L. extract and its new food antioxidant formulations induce apoptosis through mitochondrial/ caspase pathway in leukemia L1210 cells. Interdisciplinary Toxicology. 7(3), pp. 146–153.
  • Jiang, Y., Zhang, L. & Rupasinghe, H.P.V., 2017. Antiproliferative effects of extracts from Salvia officinalis L. and Saliva miltiorrhiza Bunge on hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy, 85, pp.57–67.
  • Kleinsimon, S. et al., 2017. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs. BMC complementary and alternative medicine, 17(1), p.26.
  • Li, L. et al., 2016. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget, 7(14), pp.18021–18035.
  • Li, R.Z. & Wang, L.M., 2016. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma. World J Surg Oncol, 14(1), p.150.
  • Miller, M. A. et al., 2015. Neutral red cytotoxicity assays for assessing in vivo carbon nanotube ecotoxicity in mussels — Comparing microscope and microplate methods. Mar Pollut Bull, 101(2), pp. 903–907.
  • Repetto, G., del Peso, A. and Zurita, J. L., 2008 Neutral red uptake assay for the estimation of cell viability/cytotoxicity, Nat Prot, 3(7), pp. 1125–1131.
  • Ru, J.Y. et al., 2015. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population. International Journal of Clinical and Experimental Pathology, 8(3), pp.3198–3203.
  • Serakta, M. et al., 2013. Antileishmanial activity of some plants growing in algeria: Jugulans Regia, Lawsonia Inermis And Salvial Officinalis. African Journal of Traditional, Complementary and Alternative medicines, 10(3), pp.427–430.
  • Sertel, S. et al., 2011. Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1). HNO, 59(12), pp.1203–1208.
  • Shahneh, F.Z. et al., 2013. Inhibitory and cytotoxic activities of Salvia officinalis l. Extract on human lymphoma and leukemia cells by induction of apoptosis. Advanced Pharmaceutical Bulletin, 3(1), pp.51–55.
  • Shaikh, A.B. et al., 2016. Present advances and future perspectives of molecular targeted therapy for osteosarcoma. International Journal of Molecular Sciences, 17(4).
  • Stefanović, O.D., Stanojević, D.D. & Čomić, L.R., 2012. Synergistic antibacterial activity of Salvia officinalis and Cichorium intybus extracts and antibiotics. Acta Poloniae Pharmaceutica - Drug Research, 69(3), pp.457–463.
  • van Tonder, A., Joubert, A. M. and Cromarty, A., 2015 Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays, BMC Res Notes, 8(1), p. 47.
  • Tularat, S. et al., 2013. In vitro effects of Salvia officinalis L. essential oil on Candida albicans. Asian Pacific journal of tropical biomedicine, 3(5), pp.376–80.
  • Vladimir-Knezevic, S. et al., 2014. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the lamiaceae family. Molecules, 19(1), pp.767–782.
  • Yılmaz, D. & Gökduman, M.E., 2015. Adaçayı (Salvia officinalis l.) Bitkisinin Farklı Nem Düzeylerinde Fiziko-Mekanik Özelliklerinin Belirlenmesi. Süleyman Demirel Üniversitesi Ziraat Fakültesi Dergisi, 10 (1), pp.73-82.
Year 2018, Volume: 18 Issue: 2, 420 - 425, 31.08.2018

Abstract

References

  • Abu-Darwish, M.S. et al., 2013. Essential Oil of Common Sage ( Salvia officinalis L.) from Jordan: Assessment of Safety in Mammalian Cells and Its Antifungal and Anti-Inflammatory Potential. BioMed Research International, 2013, pp.1–9.
  • Ando, K. et al., 2013. Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers, 5, pp.591–616..
  • Bauer, J. et al., 2012. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1. The Journal of pharmacology and experimental therapeutics, 342(1), pp.169–76..
  • Behradmanesh, S., Derees, F. & Rafieian, M., 2013. Effect of Salvia officinalis on diabetic patients. Journal of Renal Injury Prevention, 2(2), pp.51–4.
  • Garcıa, C.S.C. et al., 2016. Pharmacological perspectives from Brazilian Salvia officinalis (Lamiaceae): antioxidant, and antitumor in mammalian cells. Anais da Academia Brasileira de Ciências, 88(1), pp.281–292.
  • Hirahata, M. et al., 2016. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Cancer Medicine, 5(5), pp.892–902.
  • Jantová , S. et al., 2014. Salvia officinalis L. extract and its new food antioxidant formulations induce apoptosis through mitochondrial/ caspase pathway in leukemia L1210 cells. Interdisciplinary Toxicology. 7(3), pp. 146–153.
  • Jiang, Y., Zhang, L. & Rupasinghe, H.P.V., 2017. Antiproliferative effects of extracts from Salvia officinalis L. and Saliva miltiorrhiza Bunge on hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy, 85, pp.57–67.
  • Kleinsimon, S. et al., 2017. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs. BMC complementary and alternative medicine, 17(1), p.26.
  • Li, L. et al., 2016. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget, 7(14), pp.18021–18035.
  • Li, R.Z. & Wang, L.M., 2016. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma. World J Surg Oncol, 14(1), p.150.
  • Miller, M. A. et al., 2015. Neutral red cytotoxicity assays for assessing in vivo carbon nanotube ecotoxicity in mussels — Comparing microscope and microplate methods. Mar Pollut Bull, 101(2), pp. 903–907.
  • Repetto, G., del Peso, A. and Zurita, J. L., 2008 Neutral red uptake assay for the estimation of cell viability/cytotoxicity, Nat Prot, 3(7), pp. 1125–1131.
  • Ru, J.Y. et al., 2015. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population. International Journal of Clinical and Experimental Pathology, 8(3), pp.3198–3203.
  • Serakta, M. et al., 2013. Antileishmanial activity of some plants growing in algeria: Jugulans Regia, Lawsonia Inermis And Salvial Officinalis. African Journal of Traditional, Complementary and Alternative medicines, 10(3), pp.427–430.
  • Sertel, S. et al., 2011. Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1). HNO, 59(12), pp.1203–1208.
  • Shahneh, F.Z. et al., 2013. Inhibitory and cytotoxic activities of Salvia officinalis l. Extract on human lymphoma and leukemia cells by induction of apoptosis. Advanced Pharmaceutical Bulletin, 3(1), pp.51–55.
  • Shaikh, A.B. et al., 2016. Present advances and future perspectives of molecular targeted therapy for osteosarcoma. International Journal of Molecular Sciences, 17(4).
  • Stefanović, O.D., Stanojević, D.D. & Čomić, L.R., 2012. Synergistic antibacterial activity of Salvia officinalis and Cichorium intybus extracts and antibiotics. Acta Poloniae Pharmaceutica - Drug Research, 69(3), pp.457–463.
  • van Tonder, A., Joubert, A. M. and Cromarty, A., 2015 Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays, BMC Res Notes, 8(1), p. 47.
  • Tularat, S. et al., 2013. In vitro effects of Salvia officinalis L. essential oil on Candida albicans. Asian Pacific journal of tropical biomedicine, 3(5), pp.376–80.
  • Vladimir-Knezevic, S. et al., 2014. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the lamiaceae family. Molecules, 19(1), pp.767–782.
  • Yılmaz, D. & Gökduman, M.E., 2015. Adaçayı (Salvia officinalis l.) Bitkisinin Farklı Nem Düzeylerinde Fiziko-Mekanik Özelliklerinin Belirlenmesi. Süleyman Demirel Üniversitesi Ziraat Fakültesi Dergisi, 10 (1), pp.73-82.
There are 23 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Dilek Göktürk This is me

Publication Date August 31, 2018
Submission Date March 13, 2017
Published in Issue Year 2018 Volume: 18 Issue: 2

Cite

APA Göktürk, D. (2018). Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi, 18(2), 420-425.
AMA Göktürk D. Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi. August 2018;18(2):420-425.
Chicago Göktürk, Dilek. “Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi”. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi 18, no. 2 (August 2018): 420-25.
EndNote Göktürk D (August 1, 2018) Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi 18 2 420–425.
IEEE D. Göktürk, “Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi”, Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi, vol. 18, no. 2, pp. 420–425, 2018.
ISNAD Göktürk, Dilek. “Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi”. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi 18/2 (August 2018), 420-425.
JAMA Göktürk D. Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi. 2018;18:420–425.
MLA Göktürk, Dilek. “Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi”. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi, vol. 18, no. 2, 2018, pp. 420-5.
Vancouver Göktürk D. Adaçayı Bitkisinin Osteosarkoma (U-2 OS) Hücre Hattındaki Sitotoksik Etkisinin İncelenmesi. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi. 2018;18(2):420-5.